Tony Hagen, Senior Editor, The Center for Biosimilars

home / authors / tony-hagen-senior-editor-center-biosimilars

Articles

AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs

AMCP Nexus 2021: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium Discusses Biosimilars Such as Semglee and the Current Standing of Biosimilars, PBMs

Tony Hagen, Senior Editor, The Center for Biosimilars
October 20th 2021

Cate Lockhart, Pharm.D., Ph.D., spoke at AMCP Nexus about biosimilars, the insulin biosimilar Semglee and the role of PBMs.

Read More

AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year

AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year

Tony Hagen, Senior Editor, The Center for Biosimilars
October 19th 2021

Jen Norton spoke at AMCP Nexus about biosimilar trends of 2021 and what to expect in the next 12 months

Read More

FDA Issues Contingency Guidance for Clinical Trials Affected by COVID-19

FDA Issues Contingency Guidance for Clinical Trials Affected by COVID-19

Tony Hagen, Senior Editor, The Center for Biosimilars
March 19th 2020

CROs are also adapting to pandemic.

Read More

Latest Updated Articles

The Mainstreaming of CAR-T
Published: November 5th 2024 | Updated: November 22nd 2024
The Mainstreaming of CAR-T
© LASZLO - stock.adobe.com
Published: November 18th 2024 | Updated: November 22nd 2024
FDA Approves First-in-Class Drug for Rare Leukemia
American Lung Association logo | Image credit: ©postmodern studio stock.adobe.com
Published: November 19th 2024 | Updated: November 22nd 2024
Lung Association, Merck Partner to Raise Awareness of PAH
Feng Yu-stock.adobe.com
Published: May 8th 2024 | Updated: November 22nd 2024
FDA Sets Date for Advisory Committee Meeting for Midomafetamine for PTSD
Stepan Popov-stock.adobe.com
Published: June 5th 2024 | Updated: November 22nd 2024
Updated: FDA Committee, Concerned about Bias, Votes No on Psychedelic in PTSD
Andrey Popov-stock.adobe.com
Published: August 12th 2024 | Updated: November 22nd 2024
FDA Issues Complete Response Letter for MDMA-Assisted Therapy for PTSD
© 2024 MJH Life Sciences

All rights reserved.